Work

Phase Ib extension study of eribulin mesylate in combination with carboplatin in patients with chemotherapy-naive advanced non-small cell lung cancer (NSCLC).

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.15_suppl.e19145

Authors: Harry Raftopoulos, Joseph Aisner, Kirushna Kumar, Sanjay Goel, Christian Dittrich, Minish Jain, Prashanth Gopalakrishna, Paloma Salazar, Beverley Jones, Daniel Peter Petrylak

Institutions: Northwell Health, Hofstra University, Rutgers Cancer Institute, Meenakshi Mission Hospital and Research Centre, Albert Einstein College of Medicine, Kaiser-Franz-Josef-Spital, Ruby Hall Clinic, Eisai (United Kingdom), Eisai (United States), Yale University

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2520037235

Cites:

Cited by: 5

Related to: 10